Odey AM employee assets restricted by FCA

Client assets remain unrestricted

James Baxter-Derrington
clock • 2 min read

Employees of Odey Asset Management, including eponymous founder Crispin Odey, are no longer able to access any funds they have invested with the firm without the prior written consent of the Financial Conduct Authority.

According to the FCA register, Odey Asset Management and Odey Wealth Management will be restricted from transacting any instructions initiated by clients who are also "controllers, members, officers or employees" of the firms. Clients who are not related to the firms in this way will be able to continue instructing the firm on transactions, which would be considered the "ordinary course of business", according to the regulator. Odey Special Situations suspended following 'sizeable' redemptions The firms have been restricted from disposing of, withdrawing, transferring, dealing with...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot